FORA Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,624
| Closed | -$2.33M | – | 493 |
|
|
2025
Q1 | $2.33M | Sell |
8,624
-4,074
| -32% | -$1.1M | 0.24% | 137 |
|
|
2024
Q4 | $2.99M | Buy |
+12,698
| New | +$2.99M | 0.34% | 94 |
|
|
2024
Q3 | – | Sell |
-7,173
| Closed | -$1.74M | – | 429 |
|
|
2024
Q2 | $1.74M | Buy |
+7,173
| New | +$1.74M | 0.21% | 154 |
|
|
2024
Q1 | – | Sell |
-1,705
| Closed | -$326K | – | 398 |
|
|
2023
Q4 | $326K | Buy |
+1,705
| New | +$326K | 0.03% | 382 |
|
|
2022
Q4 | – | Sell |
-8,774
| Closed | -$1.76M | – | 452 |
|
|
2022
Q3 | $1.76M | Buy |
+8,774
| New | +$1.76M | 0.34% | 87 |
|
|
2021
Q4 | – | Sell |
-2,229
| Closed | -$421K | – | 301 |
|
|
2021
Q3 | $421K | Sell |
2,229
-435
| -16% | -$82.2K | 0.11% | 230 |
|
|
2021
Q2 | $452K | Buy |
+2,664
| New | +$452K | 0.08% | 282 |
|
|
2020
Q3 | – | Sell |
-7,026
| Closed | -$1.04M | – | 639 |
|
|
2020
Q2 | $1.04M | Buy |
+7,026
| New | +$1.04M | 0.36% | 62 |
|
|
2020
Q1 | – | Sell |
-10,529
| Closed | -$1.21M | – | 1015 |
|
|
2019
Q4 | $1.21M | Buy |
+10,529
| New | +$1.21M | 0.12% | 221 |
|